Evidence map›Paper›PMID 29544153›Full record

ArticleCancer epidemiology2018

Breast cancer in Portugal: Temporal trends and age-specific incidence by geographic regions.

Gonçalo Forjaz de Lacerda, Scott P Kelly, Joana Bastos, Clara Castro, Alexandra Mayer, Angela B Mariotto, William F Anderson

Abstract read
In one paragraph

Article in Cancer epidemiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gonçalo Forjaz de LacerdaDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA; Azores Region Cancer Registry, Azores Oncological Centre, Portugal. Electronic address: goncalo.forjaz@nih.gov.
Scott P KellyDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Joana BastosCentre Region Cancer Registry, Portuguese Institute of Oncology, Coimbra, Portugal.
Clara CastroNorthern Region Cancer Registry, Portuguese Institute of Oncology, Porto, Portugal.
Alexandra MayerSouthern Region Cancer Registry, Portuguese Institute of Oncology, Lisbon, Portugal.
Angela B MariottoDivision of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
William F AndersonDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

backgroundFemale breast cancer incidence rates have been increasing in Portugal for years. We, therefore, conducted the first nationwide breast cancer study to assess regional differences.

methodsCases were obtained from population-based cancer registries covering the country's Mainland (South, North, Centre), as well as the two Autonomous Regions (Azores and Madeira), for the time-period 1998 through 2011. Analyses were restricted to ages 30-84 years and stratified by region. We used the age-period-cohort (APC) framework to complement standard descriptive techniques and to forecast future trends. Estimable APC parameters included net drift, longitudinal age-specific incidence rate curves, and fitted age-specific incidence rate ratios.

resultsThere were 71 545 breast cancer cases diagnosed in Portugal at ages 30-84 years from 1998 to 2011. The South presented the highest age-standardized rate (155.8/100 000), while the North presented the fastest rate of increase (3.6%/year). Age-specific statistical interactions were observed between regions. Younger women in the North revealed a decreased risk of developing breast cancer compared to women from the same age group in the South and Centre, while that risk was reversed in older women (p < 0.05). We estimate that from 2014 onwards, the North might rank first among all regions.

conclusionThe variant patterns observed could be due to a combination of different screening practices and/or exposure to risk factors across regions. Disease heterogeneity among younger and older women may also explain part of the differences in age-specific rates. These results justify continued monitoring of breast cancer incidence by region.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsFemaleForecastingHumansIncidenceMass ScreeningMiddle AgedPortugalRegistriesRisk FactorsBreast cancerIncidencePortugalTrends

Identifiers

PMID29544153
PMCPMC5971140

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.